Wolters Kluwer Health is the professional’s first choice for knowledge-based information services and decision-support tools for the pharmaceutical, biotechnology and life science industries.
Wolters Kluwer Health is the professional's first choice for knowledge-based information services and decision-support tools for the pharmaceutical, biotechnology and life science industries. We provide unparalleled intelligence from pre-clinical to post-market surveillance marketed under the industry's leading information brands, Adis, IFI Patent Intelligence and Lippincott Williams & Wilkins.
Adis and Lippincott Williams & Wilkins brands offer a diverse collection of more than 300 society-affiliated and proprietary journals and newsletters that are written, edited and peer reviewed by the world's most respected professionals.
Lippincott Williams & Wilkins is backed by a reputation for medical publishing that spans more than 100 years and offers the gold standard in medical textbooks that are written by some of the most prestigious authors in the world.
Adis is responsible for two premier business intelligence databases, R&D Insight and Clinical Trials Insight, which provide information and interpretation to our clients throughout the pharmaceutical product lifecycle.
Wolters Kluwer Health is a unit of WoltersKluwer nv, a leading multinational publisher and information services company with annual revenues (2004) of €3.2 billion and employing approximately 20,000 people worldwide.
For more information please visit http://www.wkhealth.com/ps.htm
For further information on Wolters Kluwer Health products and services, please contact your local office
Chester, United Kingdom:
Tel: +44 1829 772 738
Fax: +44 1829 770 330
Madrid, Spain:
Tel: +34 91 555 4062
Fax: +34 91 555 7689
Munich, Germany
Tel: +49 89 36007 3512
Fax: +49 89 36007 3514
Milan, Italy
Tel: +39 02 423 4562
Fax: +39 02 422 1200
Paris, France
Tel: +33 1 56 99 9700
Fax: + 33 1 56 99 9710
Yardley, PA, USA
Tel: +1 267 757 3400
Fax: +1 267 757 3490
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.
Real-World Data Demonstrates Efficacy of Apretude and Cabenuva in HIV Prevention, Treatment
March 14th 2025New real-world and implementation study data highlight the efficacy of ViiV’s long-acting injectables for HIV prevention and treatment, with Apretude showing zero HIV acquisitions and Cabenuva maintaining high viral suppression rates.